Anxiety disorders

Certain anxiety disorders, which a great number of people suffer from, may be linked to activity in the gastrointestinal microbiota through the regulation of stress hormones. The discovery of the role of the microbiota in anxiety disorders allows us a glimpse of new potential avenues for treatment.

Anxiety disorders, which include phobias, generalized anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress, are characterized by both physical symptoms (tremors, palpitations, digestive spasms) and mental symptoms (anxious anticipation, hypervigilance, etc.). Fourteen percent of the European population is affected by this illness.

Microbiota activity as a regulator

The gastrointestinal microbiota plays a role in regulating anxiety symptoms related to stress through the microbiota-gut-brain axis. Recent data from humans in good health confirms hypotheses formulated with mice, suggesting that the microbiota influences mood and anxiety.

Stomach-brain paths of interaction

Intestinal microbiota-brain interactions involve the neurological pathway, through the activation of the vagus nerve and the onset of anxious signs (a knot in the stomach), and the blood, through the transportation of molecules from the intestine to the brain. The relevant molecules have several origins: bacterial molecules able to cross the lining of the brain (meninges), molecules secreted by intestinal cells (neuropeptides), and pro- or anti-inflammatory molecules (cytokines) produced by the intestine’s defense system.

New avenues for treatment

Beyond traditional treatment for anxiety disorders (psychotherapy, phytotherapy, anxiolytics, etc.), connections between the gastrointestinal microbiota and the brain are opening new avenues for treatment, such as probiotics, which aim to change the composition of the microbiota. However, the clinical effectiveness of this approach still remains to be proven.

Diseases related to the nervous system

  • Alzheimer's disease

    Alzheimer's disease, whose factors are still poorly understood, still has no effective treatment. However, a hypothesis around the role of ...
    Voir
  • Schizophrenia

    Chronic inflammation in the brain is suspected in schizophrenia. Disruptions in the gastrointestinal microbiota and the immune system may a...
    Voir
  • Parkinson's disease

    Parkinson’s disease is the second most common neurodegenerative disease in France. It progressively destroys the dopamine neurons in the bra...
    Voir
  • Autism-spectrum disorders

    Autism-spectrum disorders (ASDs) refer to the collection of neurobiological diseases that affect social interactions. They may have a gastro...
    Voir
  • Mood disorders

    Depression and bipolar disorder indicate a mood disorder. Beyond classic psychiatric treatments, research is in progress to evaluate the imp...
    Voir